Computed Tomography Assessment of Ablation Zone Enhancement in Patients With Early-Stage Lung Cancer After Stereotactic Ablative Radiotherapy

被引:3
作者
Moore, William [1 ]
Chaya, Yair [1 ]
Chaudhry, Ammar [1 ]
Depasquale, Britney [1 ]
Glass, Samantha [1 ]
Lee, Susan [1 ]
Shin, James [1 ]
Mikhail, George [1 ]
Bhattacharji, Priya [1 ]
Kim, Bong [2 ]
Bilfinger, Thomas [3 ]
机构
[1] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Radiat Oncol, Stony Brook, NY 11794 USA
[3] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA
关键词
SABR; ablation; CT; early-stage lung cancer; SOLITARY PULMONARY NODULES; BODY RADIATION-THERAPY; FDG-PET; SBRT; RECURRENCE; PREDICTOR; CT;
D O I
10.1097/RCT.0000000000000262
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction Stereotactic ablative radiotherapy (SABR) offers a curative treatment for lung cancer in patients who are marginal surgical candidates. However, unlike traditional surgery the lung cancer remains in place after treatment. Thus, imaging follow-up for evaluation of recurrence is of paramount importance. Materials and Methods In this retrospective designed Institutional Review Board-approved study, follow-up contrast-enhanced computed tomography (CT) exams were performed on sixty one patients to evaluate enhancement pattern in the ablation zone at 1, 3, 6, and 12 months after SABR. Results Eleven patients had recurrence within the ablation zone after SABR. The postcontrast enhancement in the recurrence group showed a washin and washout phenomenon, whereas the radiation-induced lung injury group showed continuous enhancement suggesting an inflammatory process. Conclusions The textural feature of the ablation zone of enhancement and perfusion as demonstrated in computed tomography nodule enhancement may allow early differentiation of recurrence from radiation-induced lung injury in patients' status after SABR or primary lung cancer.
引用
收藏
页码:804 / 809
页数:6
相关论文
共 13 条
[1]   Residual 18F-FDG-PET Uptake 12 Weeks After Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Predicts Local Control [J].
Bollineni, Vikram Rao ;
Widder, Joachim ;
Pruim, Jan ;
Langendijk, Johannes A. ;
Wiegman, Erwin M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (04) :E551-E555
[2]   MAXIMUM STANDARDIZED UPTAKE VALUE FROM STAGING FDG-PET/CT DOES NOT PREDICT TREATMENT OUTCOME FOR EARLY-STAGE NON SMALL-CELL LUNG CANCER TREATED WITH STEREOTACTIC BODY RADIOTHERAPY [J].
Burdick, Michael J. ;
Stephans, Kevin L. ;
Reddy, Chandana A. ;
Djemil, Toufik ;
Srinivas, Shyam M. ;
Videtic, Gregory M. M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (04) :1033-1039
[3]   Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome? [J].
Clarke, Katy ;
Taremi, Mojgan ;
Dahele, Max ;
Freeman, Marc ;
Fung, Sharon ;
Franks, Kevin ;
Bezjak, Andrea ;
Brade, Anthony ;
Cho, John ;
Hope, Andrew ;
Sun, Alexander .
RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) :62-66
[4]   Computed Tomography-Based Anatomic Assessment Overestimates Local Tumor Recurrence in Patients With Mass-like Consolidation After Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer [J].
Dunlap, Neal E. ;
Yang, Wensha ;
McIntosh, Alyson ;
Sheng, Ke ;
Benedict, Stanley H. ;
Read, Paul W. ;
Larner, James M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05) :1071-1077
[5]   FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer [J].
Hoopes, David J. ;
Tann, Mark ;
Fletcher, James W. ;
Forquer, Jeffrey A. ;
Lin, Pei-Fen ;
Lo, Simon S. ;
Timmerman, Robert D. ;
McGarry, Ronald C. .
LUNG CANCER, 2007, 56 (02) :229-234
[6]  
Matsuo Y, 2007, INT J CLIN ONCOL, V12, P356, DOI 10.1007/s10147-007-0691-9
[7]   Solitary pulmonary nodules: Dynamic contrast-enhanced MR imaging - Perfusion differences in malignant and benign lesions [J].
Schaefer, JF ;
Vollmar, J ;
Schick, F ;
Vonthein, R ;
Seemann, MD ;
Aebert, H ;
Dierkesmann, R ;
Friedel, G ;
Claussen, CD .
RADIOLOGY, 2004, 232 (02) :544-553
[8]   Radiobiological basis of SBRT and SRS [J].
Song, Chang W. ;
Kim, Mi-Sook ;
Cho, L. Chinsoo ;
Dusenbery, Kathryn ;
Sperduto, Paul W. .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) :570-578
[9]   Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer [J].
Takeda, Atsuya ;
Kunieda, Etsuo ;
Takeda, Toshiaki ;
Tanaka, Michio ;
Sanuki, Naoko ;
Fujii, Hirofumi ;
Shigematsu, Naoyuki ;
Kubo, Atsushi .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04) :1057-1065
[10]   The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT) [J].
Takeda, Atsuya ;
Yokosuka, Noriko ;
Ohashi, Toshio ;
Kunieda, Etsuo ;
Fujii, Hirofumi ;
Aoki, Yousuke ;
Sanuki, Naoko ;
Koike, Naoyoshi ;
Ozawa, Yukihiko .
RADIOTHERAPY AND ONCOLOGY, 2011, 101 (02) :291-297